New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
about
The Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An OverviewClinical significance of human papillomavirus genotypingThe interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study.Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance.Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer.Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation.No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women.Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma.Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature.IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Genomic instability and cancer: lessons learned from human papillomaviruses.No role for human papillomavirus in esophageal squamous cell carcinoma in China.Viral carcinogenesis: factors inducing DNA damage and virus integrationSensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA testRole of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literatureRole of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.Regulation of Notch1 gene expression by p53 in epithelial cellsRadiosensitivity in HeLa cervical cancer cells overexpressing glutathione S-transferase π 1Role of infectious diseases in human carcinogenesis.Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evidenAssociations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study.Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.Biology of HPV in HIV infection.Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group.Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicityMultiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection.HPV Vaccines: today and in the Future.Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma.Early detection of cervical carcinomas: finding an overall approachEvaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
P2860
Q26739983-779D6FD4-2A33-4C43-B251-9450F4859B07Q26771981-1D448B38-83D5-4A5A-8BF7-458CEBD7DB5DQ30454956-2F48AD7D-3DD2-445D-95C5-672774112B28Q33278623-4187D29C-C877-45D0-BA0B-59A515EFBE18Q33477468-B149BA97-0333-4FBE-8BE5-26C1DBF2BA72Q33665928-61ECF0CB-3CAC-41CB-9E36-0428E7DE21DCQ33733302-9B902E76-5E82-4C5C-9D53-E0D1739C8782Q33760459-16E1F0FF-1D6B-4A90-B39E-160B4C3B8225Q33808517-83789863-1B22-49AB-9D7F-39E7AA04BDCBQ34019049-564DBBD7-65B0-428A-B399-E249DE737922Q34050063-EB731354-49D0-4F7E-9FA2-1C952B67D4EEQ34064235-8F9929ED-848F-4063-8A84-25D25A67913DQ34173407-B2E1818D-CEAB-47CA-87F8-C20B4EF14134Q34556695-4E55276A-55F8-4F55-96CC-E02BAA729230Q34566683-14775D67-BB91-4017-8B57-2FCD3099793AQ34569181-E4C6535E-B148-4DC8-A04B-A8AE25BFFE65Q34608714-EBEBD1C2-D88A-4309-BCC3-D4B8566203C8Q34612265-A3A12355-0806-4732-85C5-97D86A0BA3B6Q34756499-E9DCC69F-1A9D-426A-9DCB-742FE4639735Q34774880-C7687D3E-289C-48EC-AF4E-AE8338684289Q35140046-99BDD1C0-EBFB-41B4-ADEA-137920626BC8Q35682056-31E7CF0D-A6CD-4244-9D3B-BA8648D33843Q35738847-C375ED12-D79C-4B6E-BBAB-8E1EEBFCD672Q35769502-396440FE-E6A9-4EF8-872F-6781AD97CCABQ35774348-B2AE4656-016B-4DB6-9BA4-57D9680821AEQ35774362-E0283481-1576-4B8A-891C-3476AC51B360Q35856917-762983B4-0E10-4971-8E35-FA3F1DD77F3FQ35943285-F17332B7-13C7-4330-BA20-897D346D3E55Q36060662-C30AD253-BF76-4733-9290-EA67759FF492Q36230946-DC1F95F8-28FB-48DC-829E-BFFB53874C43Q36280196-72B58032-03EB-484C-8875-1E44C78D7EC2Q36379258-22C32625-D0D6-4078-95D4-DE775BFE262CQ36467682-BEFFF948-07CF-4539-A19B-2C8D6EE509A7Q36524707-33B707F0-1A17-4035-A151-D31226E9E75BQ36525401-F48BC681-EEF8-4883-9A4B-5B026C80D29BQ36748493-843C7061-9FF5-4E37-BC2B-9F380AE952F4Q36976268-13DC8C52-E5EF-4E58-8678-D8E163BBDF76Q37079178-F1A3BFFA-923B-4016-AA11-87E5D9D74FAEQ37188108-6BC8CEE2-0F99-4126-91FE-36B90D69DD33Q37225246-3C01A72D-7FD4-47D9-9D15-13E2050E358D
P2860
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New markers for cervical dyspl ...... nic papillomavirus infections.
@ast
New markers for cervical dyspl ...... nic papillomavirus infections.
@en
type
label
New markers for cervical dyspl ...... nic papillomavirus infections.
@ast
New markers for cervical dyspl ...... nic papillomavirus infections.
@en
prefLabel
New markers for cervical dyspl ...... nic papillomavirus infections.
@ast
New markers for cervical dyspl ...... nic papillomavirus infections.
@en
P1476
New markers for cervical dyspl ...... nic papillomavirus infections.
@en
P2093
von Knebel Doeberitz M
P304
P356
10.1016/S0959-8049(02)00462-8
P577
2002-11-01T00:00:00Z